Literature DB >> 8452328

Measuring health-related quality of life.

G H Guyatt1, D H Feeny, D L Patrick.   

Abstract

Clinicians and policymakers are recognizing the importance of measuring health-related quality of life (HRQL) to inform patient management and policy decisions. Self- or interviewer-administered questionnaires can be used to measure cross-sectional differences in quality of life between patients at a point in time (discriminative instruments) or longitudinal changes in HRQL within patients during a period of time (evaluative instruments). Both discriminative and evaluative instruments must be valid (really measuring what they are supposed to measure) and have a high ratio of signal to noise (reliability and responsiveness, respectively). Reliable discriminative instruments are able to reproducibly differentiate between persons. Responsive evaluative measures are able to detect important changes in HRQL during a period of time, even if those changes are small. Health-related quality of life measures should also be interpretable--that is, clinicians and policymakers must be able to identify differences in scores that correspond to trivial, small, moderate, and large differences. Two basic approaches to quality-of-life measurement are available: generic instruments that provide a summary of HRQL; and specific instruments that focus on problems associated with single disease states, patient groups, or areas of function. Generic instruments include health profiles and instruments that generate health utilities. The approaches are not mutually exclusive. Each approach has its strengths and weaknesses and may be suitable for different circumstances. Investigations in HRQL have led to instruments suitable for detecting minimally important effects in clinical trials, for measuring the health of populations, and for providing information for policy decisions.

Entities:  

Mesh:

Year:  1993        PMID: 8452328     DOI: 10.7326/0003-4819-118-8-199304150-00009

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  757 in total

1.  A new tool for monitoring asthma outcomes: the ITG Asthma Short Form.

Authors:  M S Bayliss; D M Espindle; D Buchner; M S Blaiss; J E Ware
Journal:  Qual Life Res       Date:  2000       Impact factor: 4.147

Review 2.  Health-related quality of life (HR-QOL) and regulatory issues. An assessment of the European Agency for the Evaluation of Medicinal Products (EMEA) recommendations on the use of HR-QOL measures in drug approval.

Authors:  G Apolone; G De Carli; M Brunetti; S Garattini
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

Review 3.  A review of health-related quality-of-life measures in stroke.

Authors:  B A Golomb; B G Vickrey; R D Hays
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

4.  The Short Form 36 (SF-36) Health Survey: normative data for the Irish population.

Authors:  C Blake; M B Codd; Y M O'Meara
Journal:  Ir J Med Sci       Date:  2000 Jul-Sep       Impact factor: 1.568

5.  Carrier testing of children for two X linked diseases in a family based setting: a retrospective long term psychosocial evaluation.

Authors:  O Järvinen; A M Aalto; A E Lehesjoki; M Lindlöf; I Söderling; A Uutela; H Kääriäinen
Journal:  J Med Genet       Date:  1999-08       Impact factor: 6.318

6.  Design of treatment trials for functional gastrointestinal disorders.

Authors:  S J Veldhuyzen van Zanten; N J Talley; P Bytzer; K B Klein; P J Whorwell; A R Zinsmeister
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

7.  The SF-36 as a health status measure for epilepsy: a psychometric assessment.

Authors:  A Jacoby; G A Baker; N Steen; D Buck
Journal:  Qual Life Res       Date:  1999-06       Impact factor: 4.147

8.  The Assessment of Quality of Life (AQoL) instrument: a psychometric measure of health-related quality of life.

Authors:  G Hawthorne; J Richardson; R Osborne
Journal:  Qual Life Res       Date:  1999-05       Impact factor: 4.147

9.  Quality of life assessment in adults with type 1 Gaucher disease.

Authors:  B J Masek; K B Sims; C M Bove; M S Korson; P Short; D K Norman
Journal:  Qual Life Res       Date:  1999-05       Impact factor: 4.147

Review 10.  A comparative review of generic quality-of-life instruments.

Authors:  S J Coons; S Rao; D L Keininger; R D Hays
Journal:  Pharmacoeconomics       Date:  2000-01       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.